On ECHEMI
Home > Drugs > Wuhan Binhu Shuanghe Pharmaceutical Co., Ltd.
Wuhan Binhu Shuanghe Pharmaceutical Co., Ltd.
  • Founded in:

    1999-05-06
  • Country:

    China China
  • Address:

    Zuoling Industrial Park, East Lake New Technology Development Zone, Wuhan City, Hubei Province
  • Tax NO.:

    914201001777229307
  • Registered Funds:

    184.7082 million yuan
  • Website:

  • Email:

Related Drugs
Diphenhydramine Hydrochloride Injection
The main ingredient of this product is diphenhydramine, and its chemical name is: N, N-dimethyl-2-(diphenylmethoxy)ethylamine hydrochloride
Name Description Content CAS NO. Registered Holders
Diphenhydramine

It has an antihistamine effect and can compete with histamine released from tissues for the H1 receptors on effector cells, thereby stopping allergic reactions; it inhibits central nervous system activity and causes sedative and hypnotic effects; it enhances the effects of antitussive drugs; it has anti-vertigo and anti-tremor paralysis effects; it has local anesthetic, antiemetic and anti-M cholinergic effects.

More

It has an antihistamine effect and can compete with histamine released from tissues for the H1 receptors on effector cells, thereby stopping allergic reactions; it inhibits central nervous system activity and causes sedative and hypnotic effects; it enhances the effects of antitussive drugs; it has anti-vertigo and anti-tremor paralysis effects; it has local anesthetic, antiemetic and anti-M cholinergic effects.

58-73-1 3
Citicoline Sodium and Sodium Chloride Injection
The main ingredient of this product is citicoline
Name Description Content CAS NO. Registered Holders
Cytidine 5'-Diphosphocholine

It strengthens the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthens the function of the vertebral system and improves motor paralysis; improves cerebral circulation and promotes brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, which has a certain effect on promoting brain function recovery and awakening.

More

It strengthens the function of the brainstem reticular formation, especially the ascending reticular formation excitatory system which is closely related to consciousness; strengthens the function of the vertebral system and improves motor paralysis; improves cerebral circulation and promotes brain metabolism by reducing cerebral blood flow resistance and increasing cerebral blood flow, which has a certain effect on promoting brain function recovery and awakening.

987-78-0 3
Ciprofloxacin Lactate Sodium Chloride Injection
The main ingredients of this product are: Ciprofloxacin lactate Chemical name: 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7 (1-piperazinyl)-3-quinolinecarboxylic acid lactate Molecular formula: C17H18FN3O3C3H6O3 Molecular weight: 421.43
Name Description Content CAS NO. Registered Holders
Ciprofloxacin lactate

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacteriaceae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

More

Broad-spectrum antibacterial activity, especially high antibacterial activity against aerobic Gram-negative bacilli. It has good antibacterial activity in vitro against the following bacteria: most bacteria of the Enterobacteriaceae family, including Citrobacter, Enterobacter cloacae, Enterobacter aerogenes and other Enterobacteriaceae, Escherichia coli, Klebsiella, Proteus, Salmonella, Shigella, Vibrio, Yersinia, etc. It often also has antibacterial activity against multidrug-resistant bacteria. It has high antibacterial activity against penicillin-resistant Neisseria gonorrhoeae, enzyme-producing influenza bacilli and Moraxella. It has antibacterial activity against most strains of Pseudomonas such as Pseudomonas aeruginosa. This product has antibacterial activity against methicillin-sensitive Staphylococcus aureus, and only moderate antibacterial activity against Streptococcus pneumoniae, hemolytic Streptococcus and Enterococcus faecalis. It has good antimicrobial activity against Chlamydia trachomatis, Mycoplasma, Legionella, and also has antibacterial activity against Mycobacterium tuberculosis and atypical mycobacteria. Poor antibacterial activity against anaerobic bacteria. Ciprofloxacin is a bactericide that acts on the A subunit of bacterial DNA helicase, inhibiting DNA synthesis and replication, leading to bacterial death.

97867-33-9 13
Ofloxacin Eye Drops
The main ingredient of this product is ofloxacin. Its chemical name is (plusmn;)-9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7hydro-pyrido(1,2,3-de)[1,4]benzoxazine-6-carboxylic acid.
Name Description Content CAS NO. Registered Holders
Ofloxacin

It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections caused by Staphylococcus, Streptococcus pyogenes, Streptococcus pyogenes, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, Campylobacter, Peptostreptococcus, and Chlamydia. There is no cross-resistance between this product and other antibacterial drugs.

More

It works by inhibiting DNA gyrase and DNA replication in bacterial prokaryotes. Due to its unique mechanism of action, it has the characteristics of a broad antibacterial spectrum and strong antibacterial activity, and has a strong antibacterial effect on both Gram-positive and Gram-negative bacteria. It is effective against infections caused by Staphylococcus, Streptococcus pyogenes, Streptococcus pyogenes, Enterococcus, Pneumococcus, Escherichia coli, Citrobacter, Klebsiella pneumoniae, Enterobacter, Serratia, Proteus, Pseudomonas aeruginosa, Haemophilus influenzae, Acinetobacter, Campylobacter, Peptostreptococcus, and Chlamydia. There is no cross-resistance between this product and other antibacterial drugs.

82419-36-1 30
Ribavirin nasal drops
Name Description Content CAS NO. Registered Holders
Ribavirin

Antiviral effect

More

Antiviral effect

36791-04-5 33
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.